De novo variant in SCN4A causes neonatal sodium channel myotonia with general muscle stiffness and respiratory failure.


Journal

Neuromuscular disorders : NMD
ISSN: 1873-2364
Titre abrégé: Neuromuscul Disord
Pays: England
ID NLM: 9111470

Informations de publication

Date de publication:
11 2019
Historique:
received: 20 03 2019
revised: 16 06 2019
accepted: 02 09 2019
pubmed: 17 11 2019
medline: 1 9 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

Variants of the skeletal muscle sodium channel gene SCN4A are associated with different neuromuscular disorders including sodium channel myotonia. Here, we report an infant with a de novo variant in SCN4A presenting with neonatal onset of severe muscle stiffness with involvement of facial and eyelid muscles, and life-threatening events with respiratory failure due to severe apnoea and thorax rigidity. The boy dramatically improved in both respiratory and motor function under carbamazepine therapy.

Identifiants

pubmed: 31732390
pii: S0960-8966(19)31108-3
doi: 10.1016/j.nmd.2019.09.001
pii:
doi:

Substances chimiques

NAV1.4 Voltage-Gated Sodium Channel 0
SCN4A protein, human 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

907-909

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Astrid Pechmann (A)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Matthias Eckenweiler (M)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

David Schorling (D)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Dimitra Stavropoulou (D)

Department of General Pediatrics, Divisions of Neonatology/Intensive Care Medicine, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Hanns Lochmüller (H)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Children's Hospital of Eastern Ontario Research Institute; Division of Neurology, Department of Medicine, The Ottawa Hospital; and Brain and Mind Research Institute, University of Ottawa, Ottawa, Canada.

Janbernd Kirschner (J)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; Department of Neuropediatrics, University Hospital Bonn, University of Bonn, Bonn, Germany. Electronic address: janbernd.kirschner@uniklinik-freiburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH